Modifiable Risk Factors, Health Profile and Well-Being of the Elderly Diagnosed with Cancer in Italy: Passi d'Argento Surveillance System 2016-2019 Results.
Italy
cancer survivors
elderly
epidemiology
health promotion
prevention
public health
risk factors
surveillance system
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 Dec 2022
14 Dec 2022
Historique:
received:
09
10
2022
revised:
25
11
2022
accepted:
09
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
(1) Cases of cancer are expected to increase in the next years and the risk of cancer increases with age. Data 2016-2019 from the Italian population-based surveillance PASSI d'Argento (PdA) allow the description of the physical and psychosocial well-being of people aged ≥65 years diagnosed with cancer (Ca), and the comparison with elderly suffering from other chronic conditions (Ch) and healthy older individuals (H). (2) Data are collected by Local Health Units' professionals using a standardized questionnaire during telephone interviews. (3) A total of 8051 out of the 56,352 interviewees reported a previous diagnosis of cancer: an annual average cancer prevalence of 12.8% (95% CI 12.4-13.3%) corresponding to 1.725 million elderly residing in Italy. In comparison to the H, Ca were more likely to refer bad health (aPR = 4.21; 95% CI: 3.70-4.79), suffer from depressive symptoms (aPR = 2.65; 95% CI: 2.35-2.99), disability (aPR = 2.50; 95% CI: 2.22-2.81) or sensory problems (aPR = 1.51; 95% CI: 1.40-1.63), be frail (aPR = 1.45; 95% CI: 1.30-1.61). Ca are often current smokers (aPR = 1.26; 95% CI: 1.11-1.45) and sedentary (aPR = 1.10; 95% CI: 1.03-1.18). (4) PdA provides valuable information to researchers and policy-makers by showing the difficulties for older people with cancer in contributing socially and accessing basic social and health services, which amplifies the risk of cognitive decline, isolation, and psychological deterioration.
Identifiants
pubmed: 36551670
pii: cancers14246185
doi: 10.3390/cancers14246185
pmc: PMC9776525
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Clin Oncol. 2005 Dec 20;23(36):9295-303
pubmed: 16361628
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Am J Lifestyle Med. 2017 Mar 28;12(3):200-210
pubmed: 30202392
J Natl Cancer Inst. 2012 Jun 6;104(11):815-40
pubmed: 22570317
J Health Psychol. 2010 Mar;15(2):291-8
pubmed: 20207672
BMJ Open. 2018 Mar 27;8(3):e020313
pubmed: 29593021
Urol Nurs. 2007 Feb;27(1):93-4
pubmed: 17390935
Aust Health Rev. 2017 Aug;41(4):455-462
pubmed: 27712611
Ann Oncol. 2014 Oct;25(10):1901-1914
pubmed: 24769692
Eur J Cancer Care (Engl). 2018 Jul;27(4):e12853
pubmed: 29741781
J Cancer Surviv. 2011 Dec;5(4):413-9
pubmed: 21598023
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
pubmed: 24890451
J Lifestyle Med. 2021 Jan 31;11(1):1-7
pubmed: 33763336
J Clin Epidemiol. 1993 Feb;46(2):153-62
pubmed: 8437031
J Psychosom Res. 2005 Feb;58(2):163-71
pubmed: 15820844
Arch Intern Med. 2009 Dec 14;169(22):2102-8
pubmed: 20008694
Ann Ist Super Sanita. 2016 Oct-Dec;52(4):536-542
pubmed: 27999225
J Clin Epidemiol. 1999 Jul;52(7):643-51
pubmed: 10391658
Syst Rev. 2014 Oct 27;3:124
pubmed: 25348422
JACC CardioOncol. 2021 Dec 21;3(5):663-674
pubmed: 34988474
J Clin Oncol. 2012 Oct 20;30(30):3697-704
pubmed: 23008316
Ageing Res Rev. 2015 Jul;22:39-57
pubmed: 25956016
Eur J Cancer Care (Engl). 2018 Jul;27(4):e12854
pubmed: 29726050
J Natl Cancer Inst. 2015 Sep 30;107(12):djv275
pubmed: 26424778
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Geriatr Gerontol Int. 2018 Feb;18(2):216-223
pubmed: 29034615
Br J Cancer. 2020 Mar;122(7):1085-1093
pubmed: 32037402
BMC Cancer. 2018 Feb 9;18(1):169
pubmed: 29426306